Omeros Corp (OMER)
3.45
+0.14
(+4.23%)
USD |
NASDAQ |
May 17, 16:00
3.445
0.00 (0.00%)
After-Hours: 20:00
Omeros Cash from Operations (Quarterly): -41.78M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -41.78M |
December 31, 2023 | -34.82M |
September 30, 2023 | -32.65M |
June 30, 2023 | -32.34M |
March 31, 2023 | 174.54M |
December 31, 2022 | -25.38M |
September 30, 2022 | -26.44M |
June 30, 2022 | -19.47M |
March 31, 2022 | -15.19M |
December 31, 2021 | -18.22M |
September 30, 2021 | -23.66M |
June 30, 2021 | -27.59M |
March 31, 2021 | -40.25M |
December 31, 2020 | -18.41M |
September 30, 2020 | -34.94M |
June 30, 2020 | -37.60M |
March 31, 2020 | -9.141M |
December 31, 2019 | -23.01M |
September 30, 2019 | -7.522M |
June 30, 2019 | -16.59M |
March 31, 2019 | -12.95M |
December 31, 2018 | -24.66M |
September 30, 2018 | -36.87M |
June 30, 2018 | -30.91M |
March 31, 2018 | -11.30M |
Date | Value |
---|---|
December 31, 2017 | -4.172M |
September 30, 2017 | -11.19M |
June 30, 2017 | -8.159M |
March 31, 2017 | -12.70M |
December 31, 2016 | -10.86M |
September 30, 2016 | -11.22M |
June 30, 2016 | -12.80M |
March 31, 2016 | -16.63M |
December 31, 2015 | -16.60M |
September 30, 2015 | -14.59M |
June 30, 2015 | -16.54M |
March 31, 2015 | -17.48M |
December 31, 2014 | -15.69M |
September 30, 2014 | -15.94M |
June 30, 2014 | -15.27M |
March 31, 2014 | -11.14M |
December 31, 2013 | -0.296M |
September 30, 2013 | -11.04M |
June 30, 2013 | -9.393M |
March 31, 2013 | -8.968M |
December 31, 2012 | -12.78M |
September 30, 2012 | -7.401M |
June 30, 2012 | -8.861M |
March 31, 2012 | -5.505M |
December 31, 2011 | -7.361M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-41.78M
Minimum
Mar 2024
174.54M
Maximum
Mar 2023
-15.52M
Average
-24.52M
Median
Cash from Operations (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -1.572M |
Palatin Technologies Inc | -8.607M |
iBio Inc | -4.706M |
Theriva Biologics Inc | -4.881M |
Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -61.92M |
Cash from Financing (Quarterly) | 98.43M |
Free Cash Flow | -142.08M |
Free Cash Flow Per Share (Quarterly) | -0.7115 |
Free Cash Flow Yield | -66.71% |